---
$id: https://graph.org.ai/products/commodity/51121919
$type: Product
source: UNSPSC
code: "51121919"
title: "Etomoxir"
class: "51121900"
classTitle: "Drugs used for congestive heart failure"
family: "51120000"
familyTitle: "Antiarrythmics and antianginals and cardioplegics and drugs for heart failure"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Etomoxir

**UNSPSC Code**: 51121919
**Class**: [Drugs used for congestive heart failure](Drugs used for congestive heart failure.mdx)
**Family**: [Antiarrythmics and antianginals and cardioplegics and drugs for heart failure](../Antiarrythmics and antianginals and cardioplegics and drugs for heart failure.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an enzyme inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MSB3DD2XP6. European Medicines Agency schedules Etomoxir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07332MIG. Etomoxir generally arises in the molecular formula C17H23CLO4. The term ETOMOXIR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, no. 5, 1985, list 25.) Most nations schedule etomoxir under HS 29189900 and SITC 51396. As of Q4 2014, ETOMOXIR remains the US FDA Preferred Term for this commodity. Etomoxir bears US NLM identifiers UMLS ID C0059872 and NCI Concept Code C81111. SMILES: CLC1CCC(OCCCCCCC2(OC2)C(=O)OCC)CC1.

